Brenntag FY operating gross profit EUR 3.83 billion
TL;DR
Brenntag reported a slight decline in FY 2025 operating gross profit to EUR 3.8 billion, with sales and EBITA also down. Despite challenges, cash flow improved, and the company set 2026 EBITDA guidance while reducing dividends due to impairments.
Tags
Brenntag SE reported a preliminary operating gross profit of EUR 3.8 billion for the fiscal year 2025, reflecting a 1.9% decline compared to the prior year. This performance aligns with broader challenges in the chemicals and ingredients distribution sector, including subdued industrial activity and persistent pricing pressures. Total sales for the year fell to EUR 15.2 billion, a 3.7% decrease, while operating EBITA declined by 12.6% to EUR 929 million, slightly below adjusted guidance.
Despite the revenue contraction, Brenntag demonstrated resilience in cash generation, with preliminary free cash flow rising 5.4% to EUR 941 million. The company proposed a dividend of EUR 1.90 per share, representing a 10% reduction from 2024 levels. This adjustment accounts for non-cash impairments and special items totaling EUR 248 million, which reduced earnings per share to EUR 1.83 (compared to EUR 3.71 in 2024). Excluding these factors, adjusted EPS would have been EUR 3.55.
For 2026, Brenntag anticipates operating EBITDA between EUR 1,150 million and EUR 1,350 million, with a continued focus on cost discipline and organizational efficiency amid uncertain market conditions. The guidance excludes potential impacts from recent geopolitical developments in the Middle East. Full 2025 financial results will be published on March 12, 2026.
